Your browser doesn't support javascript.
loading
Quantifying the incidence of severe-febrile-illness hospital admissions in sub-Saharan Africa.
Roddy, Paul; Dalrymple, Ursula; Jensen, Tomas O; Dittrich, Sabine; Rao, V Bhargavi; Pfeffer, Daniel A; Twohig, Katherine A; Roberts, Teri; Bernal, Oscar; Guillen, Ethan.
Afiliação
  • Roddy P; Médecins Sans Frontières - Febrile Illness Diagnostic Programme, New York, United States of America.
  • Dalrymple U; University of Oxford, Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Oxford, United Kingdom.
  • Jensen TO; Médecins Sans Frontières - Febrile Illness Diagnostic Programme, New York, United States of America.
  • Dittrich S; Foundation for Innovative New Diagnostics (FIND), Geneva, Switzerland.
  • Rao VB; University of Oxford - Nuffield School of Medicine, Oxford, United Kingdom.
  • Pfeffer DA; Médecins Sans Frontières - Manson Unit (MSF UK), London, United Kingdom.
  • Twohig KA; University of Oxford, Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Oxford, United Kingdom.
  • Roberts T; Menzies School of Health Research and Charles Darwin University, Darwin, Australia.
  • Bernal O; University of Oxford, Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Oxford, United Kingdom.
  • Guillen E; Médecins Sans Frontières - Febrile Illness Diagnostic Programme, New York, United States of America.
PLoS One ; 14(7): e0220371, 2019.
Article em En | MEDLINE | ID: mdl-31344116
ABSTRACT
Severe-febrile-illness (SFI) is a common cause of morbidity and mortality across sub-Saharan Africa (SSA). The burden of SFI in SSA is currently unknown and its estimation is fraught with challenges. This is due to a lack of diagnostic capacity for SFI in SSA, and thus a dearth of baseline data on the underlying etiology of SFI cases and scant SFI-specific causative-agent prevalence data. To highlight the public health significance of SFI in SSA, we developed a Bayesian model to quantify the incidence of SFI hospital admissions in SSA. Our estimates indicate a mean population-weighted SFI-inpatient-admission incidence rate of 18.4 (6.8-31.1, 68% CrI) per 1000 people for the year 2014, across all ages within areas of SSA with stable Plasmodium falciparum transmission. We further estimated a total of 16,200,337 (5,993,249-27,321,779, 68% CrI) SFI hospital admissions. This analysis reveals the significant burden of SFI in hospitals in SSA, but also highlights the paucity of pathogen-specific prevalence and incidence data for SFI in SSA. Future improvements in pathogen-specific diagnostics for causative agents of SFI will increase the abundance of SFI-specific prevalence and incidence data, aid future estimations of SFI burden, and enable clinicians to identify SFI-specific pathogens, administer appropriate treatment and management, and facilitate appropriate antibiotic use.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Admissão do Paciente / Febre Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Admissão do Paciente / Febre Idioma: En Ano de publicação: 2019 Tipo de documento: Article